Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gareth A Jones
In Vitro and in Vivo Characterization of the Non-Peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Related publications
Effects of the Selective 5-Ht7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-Like Deficits in Rats
PLoS ONE
Multidisciplinary
Characterization of Apomictic Potential in Guayule (Parthenium Argentatum) in Vivo and in Vitro
Journal of the American Society for Horticultural Science
Horticulture
Genetics
In Vitro and in Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Effects of a Cannabinoid Receptor 2 Selective Antagonist on the Inflammatory Reaction to Titanium Particles in Vivo and in Vitro
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
A Cost-Utility Analysis of Amisulpride and Paliperidone in the Treatment of Schizophrenia
Heliyon
Multidisciplinary
Peroxisome Proliferator-Activated Receptor- As a Potential Therapeutic Target in the Treatment of Preeclampsia
Hypertension
Internal Medicine
In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia
American Journal of Psychiatry
Psychiatry
Mental Health
WITHDRAWN: Combined Calcitonin Gene-Related Peptide Receptor Antagonist, MK-8825, and Caffeine as Potential Therapeutic Target in the Nitroglycerin-Induced Rat Migraine Model (MK-8825 and Caffeine in Migraine)
Alexandria Journal of Medicine
Characterization of the in Vitro and in Vivo Properties of CFZ533, a Blocking and Non-Depleting Anti-Cd40 Monoclonal Antibody
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
